VLA1553-403 Pregnancy Surveillance Study

NCT07414524 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Chikungunya Virus Infection

Interventions

BIOLOGICAL: Live-attenuated CHIKV vaccine VLA1553
BIOLOGICAL: Vaccine(s) approved for use during pregnancy by the MoH

Sponsor

Valneva Austria GmbH

Collaborators

[object Object]
[object Object]